BUY 1 GET 1 50% OFF
no code needed

every product, sitewide — no code, applied automatically at checkout

side-by-side research comparison

GLP-3 RTA vs Selank

GLP-3 RTA and Selank come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.

✓ both US-made · third-party tested · batch COA on every order

Last updated August 25, 2026

How do GLP-3 RTA and Selank differ?

GLP-3 RTA (Synthetic triple-agonist peptide) is catalogued under weight & metabolic research; Selank (Synthetic heptapeptide) is catalogued under mind & sleep research. Verve lists 5 reported research applications for GLP-3 RTA and 5 for Selank. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.

GLP-3 RTA compared with Selank across compound class, research area, supply format, purity standard, documentation, catalog price and stock.
fieldGLP-3 RTASelank
compound classSynthetic triple-agonist peptideSynthetic heptapeptide
research areaweight & metabolicmind & sleep
reported research applications5 listed5 listed
supplied assingle compoundsingle compound
catalog sizes10mg · 20mg · 30mg10mg
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
endotoxin-tested optionavailableavailable
co-formulated together innot co-formulatednot co-formulated
price from$142.99$64.99
availabilityin stockin stock

Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.

What is GLP-3 RTA and what is Selank?

GLP-3 RTA is classified as Synthetic triple-agonist peptide; Selank as Synthetic heptapeptide. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.

GLP-3 RTA

Synthetic triple-agonist peptide

GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.

full GLP-3 RTA profile →

Selank

Synthetic heptapeptide

Selank is a synthetic heptapeptide, a seven-amino-acid chain built from the endogenous immunomodulatory tetrapeptide tuftsin with a C-terminal Pro-Gly-Pro extension added to increase stability. Verve supplies it as a high-purity research compound for neuroscience and peptide-signaling research.

full Selank profile →

Which research models is each compound studied in?

GLP-3 RTA sits in weight & metabolic research and Selank in mind & sleep research, so their listed models largely do not intersect. The table lists 5 reported research applications for GLP-3 RTA and 5 for Selank. Rows are per compound, not equivalences.

Reported research applications listed for GLP-3 RTA and for Selank. Entries are listed per compound; a shared row is not a claim that the two applications are equivalent.
GLP-3 RTA — reported research applicationsSelank — reported research applications
GLP-1, GIP, and glucagon receptor agonism researchRegulatory-neuropeptide signaling research
cAMP and class B GPCR signaling research modelsGABAergic and monoaminergic pathway research models
Comparative single-, dual-, and triple-agonist pharmacology studiesNeurotrophic gene-expression studies
Metabolic-pathway and nutrient-handling research modelsTuftsin-analog structure–activity research
Peptide half-life, lipidation, and stability researchPeptide-stability and degradation-kinetics research

Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.

What sizes and prices does verve list for GLP-3 RTA and Selank?

GLP-3 RTA is listed from $142.99 and Selank from $64.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.

Catalog sizes, single-vial prices and stock status for GLP-3 RTA and Selank.
compoundsize listedpriceavailability
GLP-3 RTA10mg$142.99in stock
GLP-3 RTA20mg$242.99in stock
GLP-3 RTA30mg$328.99in stock
Selank10mg$64.99in stock

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

shop the compounds →

Frequently asked questions about GLP-3 RTA and Selank

What is GLP-3 RTA?

GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is GLP-3 RTA studied for in research?

In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.

What is Selank?

Selank is a synthetic seven-amino-acid peptide derived from the tetrapeptide tuftsin with a stabilizing Pro-Gly-Pro extension. Verve supplies it as a research compound for laboratory use only.

What is Selank studied for in research?

It is used as a model neuropeptide in GABAergic and monoaminergic signaling research, neurotrophic gene-expression studies, and peptide-stability work. It is not for human or veterinary use.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.